0001104659-23-122940.txt : 20231201
0001104659-23-122940.hdr.sgml : 20231201
20231201203135
ACCESSION NUMBER: 0001104659-23-122940
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231116
FILED AS OF DATE: 20231201
DATE AS OF CHANGE: 20231201
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MALIK NAVID
CENTRAL INDEX KEY: 0001629113
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35737
FILM NUMBER: 231461127
MAIL ADDRESS:
STREET 1: 1 CHOLMELEY PARK
STREET 2: HIGHGATE
CITY: LONDON
STATE: X0
ZIP: N6 5ET
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NORTHWEST BIOTHERAPEUTICS INC
CENTRAL INDEX KEY: 0001072379
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943306718
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4800 MONTGOMERY LANE
STREET 2: SUITE 800
CITY: BETHESDA
STATE: MD
ZIP: 20814
BUSINESS PHONE: (240) 497-9024
MAIL ADDRESS:
STREET 1: 4800 MONTGOMERY LANE
STREET 2: SUITE 800
CITY: BETHESDA
STATE: MD
ZIP: 20814
4
1
tm2331758d1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2023-11-16
0
0001072379
NORTHWEST BIOTHERAPEUTICS INC
NWBO
0001629113
MALIK NAVID
C/O NORTHWEST BIOTHERAPEUTICS, INC.
48 MONTGOMERY LANE, SUITE 800
BETHESDA
MD
20814
1
0
0
0
0
Common Stock
2023-11-16
4
S
0
125000
0.835
A
445000
D
Common Stock
2023-11-17
4
S
0
150000
0.823
A
295000
D
Common Stock
2023-11-17
4
S
0
295000
0.819
A
0
D
Dr. Malik sold a total of 570,000 shares solely to pay a tax obligation, and all proceeds are being used for such taxes.
/s/ Navid Malik
2023-12-01